GLP-1 drugs, originally developed to treat type 2 diabetes, have undergone a remarkable transformation in recent years, emerging as popular weight loss solutions. This shift has sparked a cultural moment, with medications like Ozempic and Wegovy becoming part of everyday conversations and dominating social media feeds. Read more to learn insights from Dentsu's study of 1,000 US consumers.